Inside the Diagnostics Industry: Software Tailors NGS Results for Maximum Clinical Utility
Software maker Syapse (Palo Alto, Calif.) is on a mission to bring best-in-practice software to the genomics industry. Syapse has developed a software platform that serves as a functional bridge between laboratory information systems (LISs) and electronic medical records (EMRs). Syapse software allows labs and care providers to provide interactive molecular diagnostic test reports and decision support to providers across the clinical spectrum—from genetic counselors to oncologists or primary care physicians and even directly to patients. The software can aggregate omics, medical history, and outcomes data, and connect to third-party commercial interpretation providers, as well as public and open databases, such as ClinVar, COSMIC, PhenoDB, and OMIM. It can also accommodate clients’ proprietary knowledge and care pathways. DTET recently spoke with Jonathan Hirsch, the founder and president of Syapse, to understand how Syapse’s software can expedite the transition of molecular diagnostics and next-generation sequencing (NGS) into routine clinical practice and how the software can enhance the value proposition of NGS-based testing. The quantity of data generated from NGS-based testing is often cited as a barrier to clinical adoption. How does Syapse help alleviate this data bottleneck? Syapse is, at the end of the day, a software company that is bringing […]
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article